Free public records show Jeil Pharmaceutical Co., Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Jeil Pharmaceutical Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Jeil Pharmaceutical Co., Ltd., of 37 in all
Source: ClinicalTrials.gov, Studies with Jeil Pharmaceutical Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
38 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Jeil Pharmaceutical Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Jeil Pharmaceutical Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Jeil Pharmaceutical Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Jeil Pharmaceutical Co., Ltd. is in.
Stories on the topics Jeil Pharmaceutical Co., Ltd. works in.
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read
Gut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or…
Read
Up to 20% of people in the US have GERD, and it led to 26.7 million US clinic visits in 2015. Most cases can…
ReadSearch all reports for Jeil Pharmaceutical Co., Ltd. All companies